EDINBURGH, Scotland, June 23, 2014 /PRNewswire/ --

Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces its Calcivis® Caries Activity Imaging System will be presented at two international dental conferences in the coming weeks.

Calcivis Chief Technical Officer, Bruce Vernon, is giving a presentation on the development of the system at the International Association for Dental Research (IADR) conference in Cape Town, South Africa, on the 25^th June. The talk will focus on optimising the sensitivity of the system which comprises a sophisticated medical device and consumable combination designed to transform the assessment of dental caries (tooth decay).

Dr Chris Longbottom, from the Dental Innovation and Translation Centre at King's College London, who has collaborated on the development of the Calcivis approach, is presenting a poster at the European Organisation for Caries Research Congress (ORCA) in Germany from 2^nd - 5^th July. The poster evaluates the effect of toothpastes on demineralisation images produced by the Calcivis system.

The Calcivis® Caries Activity Imaging System is an in-clinic device which combines a sensitive intraoral camera and application technology to deliver a precise amount of disclosing solution, containing a photoprotein, onto the tooth surface.

The photoprotein binds calcium ions and emits a blue light signal proportional to the amount of calcium present. This exquisitely sensitive chemiluminescent system produces a demineralisation map of the tooth. The resulting images provide a focus for discussion with patients about their caries management programme and the development of a tailored, rational, evidence-based treatment in line with dental best practice.

About Calcivis 

Calcivis is an innovative medical devices company focused on revolutionising the management of dental caries or 'tooth decay'. Based in Edinburgh, Scotland, Calcivis brings together novel biotechnology approaches and world-class device development expertise and is at the forefront of applying biotechnology to dentistry.

The Calcivis® Caries Activity Imaging System will, for the first time, allow the real-time detection and visualisation of calcium ions released by demineralising caries lesions in routine dental practice.

The Calcivis approach is being developed with input from leading specialists in caries detection, assessment and management; Professor Nigel Pitts and Dr Christopher Longbottom (Dental Innovation and Translation Centre, King's College London Dental Institute) both internationally renowned for cariology, health services and translational research.

Calcivis was established in 2011 and has completed two fundraisings led by Archangel Informal Investment and including the Scottish Co-Investment Fund and Scottish Investment Bank.  http://www.calcivis.com

Contacts
Adam Christie, CEO                    
Tel: +44(0)7795-600571                                  
E-mail: info@calcivis.com

Chris Gardner, Citigate Dewe Rogerson            
Tel: +44(0)207-638-9571                                    
E-mail: chris.gardner@citigatedr.co.uk

SOURCE Calcivis